Furthermore, several key baseline characteristics were also different between the two study populations
Specifically, GGCT has been confirmed to activate the PI3K/AKT/mTOR signaling, thereby driving the malignant progression of ovarian cancer, hepatocellular carcinoma, and breast cancer [11,12,13]
13 , 15 Although the magnitude of this effect in clinical settings remains unclear, there is a biological rationale to consider an elevated risk of volume-related symptoms in susceptible individuals, such as older adults, those with orthostatic hypotension, or patients on multidrug antihypertensive regimens
Peptide spectra matches (PSM) were validated using Percolator with a minimum probability setting of 0.5